Doximity, Inc. (DOCS) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Doximity Announces Fiscal 2024 Second Quarter Financial Results
November 9, 2023 4:01 PM EST
Total revenues of $113.6 million, up 11% year-over-year
Net income margin of 27% and adjusted EBITDA margin of 48%
Net income growth of 16% and adjusted EBITDA growth of 18% year-over-year
SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 second quarter ended September 30, 2023.
Were proud to make medicine mobile, with another quarter of record engagement across our entire platform, said Jeff Tangney, co-founder and CEO of Doximity. Over 550,000 unique providers used our generative AI,... More
